Glatiramer acetate therapy: the plot thickens.
Karandikar
Nitin J
NJ
Racke
Michael K
MK
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000068717:Glatiramer Acetate; D006801:Humans; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use*; D019707:Receptors, Chemokine / Q000096:biosynthesis
D000276:Adjuvants, Immunologic; D010455:Peptides; D019707:Receptors, Chemokine; D000068717:Glatiramer Acetate